StockData
ASP Isotopes Inc. logo

ASP Isotopes Inc. (ASPI) company profile

ASPINasdaqMiscellaneous Chemical ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3074% below fair value
$1.37−0.17 (-11.04%)

Close on Nov 17, 2026Market cap $210.03MP/E –Yield –

About ASP Isotopes

Miscellaneous Chemical Products, SIC 2890

ASP Isotopes develops materials and isotope enrichment technologies across three operating segments: specialist isotopes, nuclear fuels, and construction services. The specialist isotopes business separates isotopes including Carbon-14, Silicon-28, and Ytterbium-176, and produces radiopharmaceuticals via PET Labs. The nuclear fuels segment focuses on advanced fuels such as high-assay low-enriched uranium. The construction segment undertakes public civil engineering projects, such as road and drainage works. Through Renergen, the company also produces liquefied natural gas and liquid helium. Its customers include pharmaceutical developers, semiconductor companies, nuclear energy firms, and domestic natural gas consumers.

The company operates facilities across South Africa, the United Kingdom, the United States, and Hong Kong. In South Africa, it maintains isotope enrichment plants in Pretoria and gas production assets covering over 187,000 hectares in Free State Province. Civil engineering operations are located in Hong Kong. The text does not state the location of the company's headquarters.

Summary of the business section of ASP Isotopes's latest annual report, written by StockData.

Company profile

Company

Legal name
ASP Isotopes Inc.
Headquarters
Dallas, TX
Address
2200 Ross Avenue, Suite 4575e 75201
Phone
(202) 756-2245
Employees
271, Dec 31, 2025
Industry
Miscellaneous Chemical Products
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
EISNERAMPER LLP, Iselin, New Jersey

Stock & identifiers

Ticker
ASPI
Exchange
Nasdaq
IPO date
Nov 14, 2022
Shares outstanding
153M, Aug 14, 2026
Public float
$399.80M, Jun 30, 2025
Filer category
<br>Emerging growth company
SEC CIK
1921865
CUSIP
00218A105
ISIN
US00218A1051
FIGI
BBG013Y062J3
Share class FIGI
BBG013Y062L0
LEI
6488WHV94BZ496OZ3219
EIN
87-2618235

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Paul Elliot MannChairman and CEO, Director9,328,570
Heather KiesslingChief Financial Officer1,504,422
Robert AinscowCOO2,225,941
Donald George AinscowEVP, Gen Counsel, Secretary776,322
Robert John Andrew RyanDirector675,222
Todd WiderDirector672,247
Michael GorleyDirector87,908
Duncan MooreDirector1,044,928
Ralph L. Hunter JRDirector47,018

Executive compensation, fiscal 2024

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsTotalvs. prior year
Paul Mann
Executive Chairman
$510.00K$500.00K$3.76M$4.77M+115%
Heather Kiessling
Chief Financial Officer (1)
$200.00K$200.00K$1.31M$1.71M–
Robert Ainscow
Interim Chief Executive Officer and Chief Operating Officer (1)
$310.00K$180.00K$658.50K$1.15M+359%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Nov 14, 2022
Offer price
$4.00
Securities offered
1,250,000
Gross proceeds
$5.00M
Exchange
Nasdaq
First trading day
Nov 11, 2022
First-day close
$2.80-30.0%
Lock-up ends (est.)
May 10, 2023

“The initial public offering price per share is $4.00.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we employed 271 people on a full-time basis.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?